Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ1R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,874
Award facts
- Contract value 100% obligated
- $56,873.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $56,873.76 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 40 gram/400 milliliter vials. This firm fixed-price, non-competitive delivery order is scheduled for completion by February 3, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin therapy used to treat various immunological disorders, representing part of the Defense Logistics Agency's critical pharmaceutical supply chain supporting military healthcare systems.
This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 2031. This comprehensive IDC serves as the primary contracting mechanism for supplying a wide range of pharmaceutical products, specialty medications, biologics, and medical supplies to support military treatment facilities and veterans' healthcare programs globally. The non-set-aside competitive structure of AmerisourceBergen's federal contract portfolio demonstrates the company's established capability to meet rigorous federal procurement standards for pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FCZ1R?
SPE2DR26FCZ1R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FCZ1R worth?
The government has obligated $56,874 on SPE2DR26FCZ1R.
Is contract SPE2DR26FCZ1R an order under another contract?
Yes. SPE2DR26FCZ1R is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ1R competed?
The extent of competition for SPE2DR26FCZ1R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award